Insider Trading23 Jun 2026, 06:50 pm
Brooks Laboratories Closes Trading Window for Q2 2026 Results
AI Summary
Brooks Laboratories Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This restriction will be in effect from July 1, 2026, until 48 hours after the declaration of the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026. The closure aligns with SEBI (Prohibition of Insider Trading) Regulations and the company's internal code of conduct, aimed at preventing insider trading during the period leading up to and immediately following the financial results announcement.
Key Highlights
- Trading window closed from July 1, 2026.
- Closure is for Q2 FY26 financial results announcement.
- Applies to designated persons and immediate relatives.
- Aims to prevent insider trading as per SEBI regulations.
Price Impact
More from BROOKS